A novel germline frameshift mutation in the MLH1 gene in a patient with Lynch syndrome.

[1]  P. Peltomäki.  Update on Lynch syndrome genomics , 2016, Familial Cancer.

[2]  Bale,et al.  Standards and Guidelines for the Interpretation of Sequence Variants: A Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology , 2015, Genetics in Medicine.

[3]  J. Lubiński,et al.  Germline deletions in the EPCAM gene as a cause of Lynch syndrome – literature review , 2013, Hereditary cancer in clinical practice.

[4]  H T Lynch,et al.  Review of the Lynch syndrome: history, molecular genetics, screening, differential diagnosis, and medicolegal ramifications , 2009, Clinical genetics.

[5]  J. Mecklin,et al.  The risk of extra‐colonic, extra‐endometrial cancer in the Lynch syndrome , 2008, International journal of cancer.

[6]  E. Oláh,et al.  Germline MLH1 and MSH2 mutational spectrum including frequent large genomic aberrations in Hungarian hereditary non-polyposis colorectal cancer families: implications for genetic testing. , 2007, World journal of gastroenterology.

[7]  M. Kloor,et al.  Genotype-phenotype comparison of German MLH1 and MSH2 mutation carriers clinically affected with Lynch syndrome: a report by the German HNPCC Consortium. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  H T Lynch,et al.  New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. , 1999, Gastroenterology.